Model
Edge
Arca Biopharma Inc.
ABIO
Filing Type
8-K
Filing Date
8/23/2026
Updated
8/24/26, 2:10 PM
Copy Ref
Filing
8-K
Earnings Release
Exhibits
8-K
Changes in Board, Management or Compensation
EX-10.1
OFFER LETTER, DATED JULY 22, 2026, BETWEEN ORUKA THERAPEUTICS, INC. AND TODD EDWARDS
GRAPHIC
Graphic